Detalles de la búsqueda
1.
Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry.
Acta Neuropathol
; 147(1): 87, 2024 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38761203
2.
Embedding Patient Input in Outcome Measures for Long-Term Disease-Modifying Parkinson Disease Trials.
Mov Disord
; 39(2): 433-438, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38140767
3.
Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson's disease.
Brain
; 146(7): 2717-2722, 2023 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36856727
4.
Patient and Public Involvement and Engagement in the Development of a Platform Clinical Trial for Parkinson's Disease: An Evaluation Protocol.
J Parkinsons Dis
; 14(4): 809-821, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38701161
5.
An International Multi-Stakeholder Delphi Survey Study on the Design of Disease Modifying Parkinson's Disease Trials.
J Parkinsons Dis
; 13(8): 1343-1356, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38007672
6.
Incorporating usability evaluation into iterative development of an online platform to support research participation in Parkinson's disease: a mixed methods protocol.
BMJ Open
; 13(12): e078638, 2023 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38114283
7.
Investigating trial design variability in trials of disease-modifying therapies in Parkinson's disease: a scoping review protocol.
BMJ Open
; 13(12): e071641, 2023 12 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38070893
8.
Outcome Measures for Disease-Modifying Trials in Parkinson's Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative.
J Parkinsons Dis
; 13(6): 1011-1033, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37545260
9.
Is It Possible to Conduct a Multi-Arm Multi-Stage Platform Trial in Parkinson's Disease: Lessons Learned from Other Neurodegenerative Disorders and Cancer.
J Parkinsons Dis
; 10(2): 413-428, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32116263
10.
Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis.
Oncotarget
; 7(29): 46603-46614, 2016 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-27366949
Resultados
1 -
10
de 10
1
Próxima >
>>